Generex Biotechnology Corp. Logo
Generex Biotechnology Creates Scientific Advisory Board to Further the Progression of Its Drug Development Programs
August 02, 2010 09:30 ET | Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Biotechnology Corp. Logo
Generex Announces AGM Results
July 30, 2010 16:30 ET | Generex Biotechnology Corp.
WORCESTER, Mass., July 30, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced the results of the Company's annual meeting of stockholders held...
Generex Biotechnology Corp. Logo
Generex Provides Positive Update On Generex Oral-Lyn(TM) Pivotal Phase III Trial
July 28, 2010 09:30 ET | Generex Biotechnology Corp.
WORCESTER, Mass., July 28, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Biotechnology Corp. Logo
Generex's Glucose RapidSpray(TM) Now Available at Boots UK Retail Chain Stores
July 15, 2010 09:30 ET | Generex Biotechnology Corp.
WORCESTER, Mass., July 15, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Biotechnology Corp. Logo
Generex Announces Receipt of Favorable NASDAQ Listing Determination
July 15, 2010 07:34 ET | Generex Biotechnology Corp.
WORCESTER, Mass., July 15, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced its receipt of a decision by the NASDAQ Listing Qualifications...
Generex Biotechnology Corp. Logo
Generex Oncology Granted United States Patent for AE37 Peptide Vaccine
July 13, 2010 09:30 ET | Generex Biotechnology Corp.
WORCESTER, Mass., July 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced that its wholly-owned subsidiary, Antigen Express, Inc....
Generex Biotechnology Corp. Logo
Generex Biotechnology Participates in Gateway to China Business Round Table Conference
July 07, 2010 12:18 ET | Generex Biotechnology Corp.
WORCESTER, Mass., July 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced its participation in the Gateway to China Business Round Table...
Generex Biotechnology Corp. Logo
Generex Biotechnology to Participate in World's Largest and Most Prestigious Diabetes Meeting
June 22, 2010 09:30 ET | Generex Biotechnology Corp.
WORCESTER, Mass., June 22, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced its participation as an exhibitor during the 70th Scientific...
Generex Biotechnology Corp. Logo
Generex Oncology Announces Presentations at the American Society of Clinical Oncology Annual Meeting and the 7th World Vaccine Conference
June 09, 2010 09:27 ET | Generex Biotechnology Corp.
WORCESTER, Mass., June 9, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced presentations on the technologies and products under development at...
Generex Biotechnology Corp. Logo
Generex Biotechnology Reports Preliminary Outcomes and Trends From Ongoing Phase III Clinical Trial of Generex Oral-lyn(TM)
June 07, 2010 09:55 ET | Generex Biotechnology Corp.
WORCESTER, Mass., June 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...